Year: 2026
Type: article
Abstract: Purpose Cannabidiol (CBD) exhibits promising pharmacological effects for the treatment of various medical conditions. However, its poor aqueous solubility and pronounced lipophilicity lead to low oral bioavailability, limiting its therapeutic potential. This study aims to develop and evaluate a new Oiling-Out production strategy based on spray drying. The obtained CBD containing powders are characterized by their particle properties and dissolution behavior. Methods This approach focuses on particle size reduction by generating submicron CBD droplets via a continuous Oiling-Out process, followed by immediate embedding in a polymeric carrier during spray drying. Since mixing conditions strongly influence droplet size, Computational Fluid Dynamics (CFD) simulations were employed to analyze mixing performance and residence time in two mixer configurations: a T-mixer and a swirl mixer. Pure CBD, a physical mixture as well as an amorphous solid dispersion served for comparison. Results The process led to solid systems containing CBD with enhanced dissolution behavior compared to crystalline drug substance. The drug release was even faster than the release from the amorphous solid dispersion formulation with comparable particle properties. Conclusion The study demonstrates the potential of spray drying as a versatile and scalable process for the development of solid formulations of poorly water-soluble drugs such as CBD. The investigated formulation strategy provides process-relevant insights for the design of spray-drying-based manufacturing routes to enhance dissolution performance and support the development of oral CBD products.
Authors: Enrico M. A. Ercolin(Conceptualization, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft), Fabian Schulte(Conceptualization, Formal analysis, Investigation, Methodology), Gerhard Schaldach(Conceptualization, Methodology, Project administration, Writing – review & editing), Jens Bartsch(Writing – review & editing), Oliver Kayser(Conceptualization, Methodology, Writing – review & editing), Markus Thommes(Supervision, Writing – review & editing)
Institution: TU Dortmund University
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $3,990
Funder: Technische Universität Dortmund
OpenAlex ID: W7235775571
